Skip to content
OpenCapital
Get started

Pulmonx Corporation LUNG Q1 2026 earnings

Reported April 29, 2026 · After market close

Revenue$20.6MBeat by $154.6K
EPS-$0.33In line
Revenue estimate$20.4M
EPS estimate-$0.33

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$51.53M-58.6%
Enterprise value$46.8M-57.0%
P/S0.6×-0.8×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Segments

By geography

See full
Europe, Middle-East and Africa (“EMEA”)$6.6M+19.9%
Asia Pacific$707.0K-74.7%
Other International$51.0K+34.2%

Versus estimates

Revenue

Q1 2026$20.6MBeat by $154.6K
Q4 2025$22.6MBeat by $869.7KQ3 2025$21.5MMiss by $226.3KQ2 2025$23.9MBeat by $466.2KQ1 2025$22.5MBeat by $505.1KQ4 2024$23.8MBeat by $1.5M

Diluted EPS

Q1 2026-$0.33In line
Q4 2025-$0.25Beat by $0.14Q3 2025-$0.34Beat by $0.06Q2 2025-$0.38Beat by $0.02Q1 2025-$0.36Beat by $0.01Q4 2024-$0.33Beat by $0.12

Ask the moment Pulmonx Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Pulmonx Corporation report Q1 2026 earnings?
Pulmonx Corporation (LUNG) reported Q1 2026 earnings on April 29, 2026 after market close.
What were Pulmonx Corporation's Q1 2026 revenue and EPS?
Pulmonx Corporation reported revenue of $20.6M and eps of $-0.33 for Q1 2026.
Did Pulmonx Corporation beat estimates in Q1 2026?
Revenue beat the consensus estimate of $20.4M by $154.6K. EPS beat the consensus estimate of $-0.33 by $0.00.
How did Pulmonx Corporation's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.7% from $22.5M a year earlier and eps grew 8.3% from $-0.36.
Where can I find Pulmonx Corporation's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001127537-26-000020) and the 10-Q periodic report (0001127537-26-000025) directly on SEC EDGAR. The filing index links above go to sec.gov.